Back to search

Peptide record

TPDB91923

[G1K, K8R]cGm Antibacterial Anticancer Antifungal Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB91923
[G1K, K8R]cGm
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 dbACP dbAMP 3.0 Antifungipept CAFPdb
standard
No
A 18-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Cyclized N-terminal: Cyclized
Sequence
KCRRLCYRQRCVTYCRGR
Physicochemical Analysis
C94H162N38O23S4
ANDEHIMFPSW
R
2320.80
10.57
7
0
4
+7
3.25
-1.117
37.78
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
3230
139.18
8
Residue Composition
number
0
A
6
R
0
N
0
D
4
C
0
E
1
Q
1
G
0
H
0
I
1
L
1
K
0
M
0
F
0
P
0
S
1
T
0
W
2
Y
1
V
Amino Acid Distribution
A: 0 R: 6 N: 0 D: 0 C: 4 E: 0 Q: 1 G: 1 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 1 W: 0 Y: 2 V: 1
Chemical Descriptors
18
C94H162N38O23S4
2320.80
10.57
+7
3.25
-1.117
Cyclized
L
Cyclic
Cyclized
Antimicrobial
Synthetic Analogue of Gomesin
Evidence Records 6 records
Evidence 1 Activity

Activity

CC50
CC50 = 19.5 ± 0.5 µM
Anticancer
19.5

Target

Gastric Cancer
CRL-1739
Stomach

Assay & Model

Resazurin dye assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2017

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 2 Activity

Activity

CC50
CC50 = 1.7 ± 0.1 µM
Anticancer
1.7

Target

Skin Cancer
MM96L
Skin

Assay & Model

Resazurin dye assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2017
Evidence 3 Activity

Activity

CC50
CC50 = 44.2 ± 2.2µM
Anticancer
44.2

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

Resazurin dye assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2017
Evidence 4 Activity

Activity

CC50
CC50 = 6.7 ± 0.7 µM
Anticancer
6.7

Target

Breast Cancer
MCF-7
Breast

Assay & Model

Resazurin dye assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2017
Evidence 5 Activity

Activity

CC50
CC50 = 2.1 ± 0.2 µM
Anticancer
2.1

Target

Leukemia Cancer
K-562
Blood

Assay & Model

Resazurin dye assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2017
Evidence 6 Activity

Activity

CC50
CC50 = 9.0 ± 1.1µM
Anticancer
9.0

Target

Leukemia Cancer
HL-60
Blood

Assay & Model

Resazurin dye assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2017